This report reevaluates the role of medical affairs in pharma and asks what may be holding them back from a greater role in digital health.The future success of medical affairs relies on this function becoming a strategic enabler of digital health activities in pharma.
Interacting with HCPs and working closely with R&D and commercial means no other function within pharma is as ideally situated to push for a greater uptake of digital health and align key external stakeholders for adoption.
In this report, we look at: